The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Clinical & Research NewsFull Access

Which Are Best for Active Mania?

Overall, antipsychotic drugs were significantly more effective than mood stabilizers for the treatment of acute mania, a difference attributable primarily to the superior efficacy of haloperidol, risperidone, and olanzapine.

Haloperidol, risperidone, olanzapine, lithium, aripiprazole, quetiapine, carbemazepine, asenapine, valproate, and ziprasidone were significantly more effective than placebo.

Olanzapine, risperidone, and quetiapine led to significantly fewer discontinuations than did lithium, lamotrigine, placebo, topiramate, and gabapentin.

Considering both efficacy and tolerability, risperidone, olanzapine, and haloperidol should be considered among the best of the available options for the treatment of manic episodes.

A major limitation of the meta-analysis is that all studies were of no more than three weeks' duration, making it impossible to assess postmania depression as well as metabolic and other side effects associated with the drugs.